Jacobs Levy Equity Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-767,135
Closed -$7.21M 1142
2020
Q3
$7.21M Sell
767,135
-28,476
-4% -$268K 0.07% 270
2020
Q2
$6.09M Sell
795,611
-679
-0.1% -$5.19K 0.07% 300
2020
Q1
$4.92M Buy
796,290
+68,903
+9% +$426K 0.06% 296
2019
Q4
$8.85M Buy
727,387
+213,067
+41% +$2.59M 0.09% 268
2019
Q3
$5.94M Buy
514,320
+66,605
+15% +$769K 0.07% 306
2019
Q2
$4.47M Buy
447,715
+179,310
+67% +$1.79M 0.06% 369
2019
Q1
$3.46M Buy
268,405
+206,972
+337% +$2.67M 0.05% 399
2018
Q4
$933K Buy
61,433
+32,633
+113% +$496K 0.02% 608
2018
Q3
$576K Sell
28,800
-85,360
-75% -$1.71M 0.01% 750
2018
Q2
$2.23M Buy
114,160
+73,560
+181% +$1.43M 0.04% 485
2018
Q1
$818K Buy
+40,600
New +$818K 0.01% 679
2015
Q1
Sell
-8,200
Closed -$349K 919
2014
Q4
$349K Buy
+8,200
New +$349K 0.01% 657
2014
Q2
Sell
-52,241
Closed -$1.01M 969
2014
Q1
$1.01M Sell
52,241
-20,800
-28% -$403K 0.02% 535
2013
Q4
$1.77M Buy
73,041
+45,281
+163% +$1.1M 0.03% 452
2013
Q3
$596K Sell
27,760
-11,000
-28% -$236K 0.01% 647
2013
Q2
$862K Buy
+38,760
New +$862K 0.02% 604